Cognition Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $250 |
Gross Profit | -61 | -61 | -45 | -71 |
EBITDA | -4,869 | -6,670 | -8,430 | -7,766 |
EBIT | -4,930 | -6,731 | -8,475 | -7,837 |
Net Income | -4,930 | -6,734 | -8,480 | -7,842 |
Net Change In Cash | 0 | 0 | 0 | 250 |
Free Cash Flow | -5,651 | -5,623 | -9,877 | -8,383 |
Cash | 39,823 | 10,743 | 16,428 | 25,009 |
Basic Shares | 77,951 | 63,690 | 61,828 | 46,431 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -266 | -252 | -235 | -93 |
EBITDA | -33,680 | -25,509 | -21,134 | -10,730 |
EBIT | -33,946 | -25,761 | -21,369 | -10,823 |
Net Income | -33,971 | -25,788 | 757 | -11,716 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -13,158 | |||
Free Cash Flow | -28,478 | -16,165 | -18,704 | -3,658 |
Cash | 25,009 | 29,922 | 41,562 | 54,721 |
Basic Shares | 39,730 | 30,029 | 28,991 | 22,230 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.11 |
2025-03-31 | -$0.14 |
